Leslie A. Leinwand, Ph.D.

Distinguished Professor of Molecular, Cellular and Developmental Biology, University of Colorado at Boulder

Cardiology, Molecular Biology, Human Genetic Disease

EDUCATION

BS – Cornell University

PhD – Yale University

Postdoctoral Fellow – Rockefeller University

AWARDS AND ACCOLADES

National Academy of Inventors

NHLBI MERIT Award

Distinguished Scientist Award, American Heart Association

Fellow, American Association for the Advancement of Science

Howard Hughes Medical Institutes Professor

Distinguished Professor, University of Colorado, Boulder

COMPANIES AND BOARDS

Co-Founder: MyoKardia (acquired by Bristol Myers Squibb), Myogen (acquired by Gilead Pharmaceuticals), Hiberna

Board of Directors: Hiberna, Global Down Syndrome Foundation

Scientific Advisory Board: Bristol Myers Squibb, Edgewise Therapeutics, Fulcrum Therapeutics, Linda Crnic Institute for Down Syndrome, Contour Therapeutics, TARA Biosystems

External Advisory Board: University of Arizona Department of Physiology; Indiana University School of Medicine; Stanford Cardiovascular Institute

MEMBER OF Investment Committee

Associated Portfolio Companies

No items found.